tradingkey.logo
tradingkey.logo
Search

Lantheus Announces Alzheimer’s Disease Radiodiagnostic Mk-6240 Meets Co-Primary Endpoints In Two Pivotal Studies

ReutersApr 30, 2025 12:36 PM
facebooktwitterlinkedin
View all comments0

- Lantheus Holdings Inc LNTH.O:

  • LANTHEUS ANNOUNCES ALZHEIMER’S DISEASE RADIODIAGNOSTIC MK-6240 MEETS CO-PRIMARY ENDPOINTS IN TWO PIVOTAL STUDIES

  • LANTHEUS HOLDINGS INC - NDA SUBMISSION FOR MK-6240 EXPECTED IN Q3 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI